Fed Decision Holds Markets Steady

Fed decision left markets muted as traders awaited Powell's forward guidance and the FOMC dot plot, keeping positioning cautious ahead of the statement.

December 10, 2025·2 min read
View all news articles
Flat vector vault under dimming light representing the Fed decision and muted markets with a smooth graphite-frost gradient.

KEY TAKEAWAYS

  • Markets were muted as traders focused on Powell's forward guidance and the FOMC's updated projections.
  • Investors broadly expected the committee to leave the policy rate unchanged at the meeting.
  • More decisive directional moves were likely after the statement and Powell's press conference Q&A.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

The Federal Reserve’s decision at 2:00 p.m. ET on Dec. 10, 2025, kept global equity markets steady to slightly weaker as investors awaited Chair Jerome Powell’s forward guidance and the Federal Open Market Committee’s (FOMC) updated projections, limiting large directional bets before the announcement.

Markets Hold Ahead of Fed Decision

U.S. equity futures were modestly negative before the cash open, implying declines of about 0.1% for the Dow and S&P 500 futures and about 0.25% for Nasdaq futures. European futures also pointed to a modestly negative open, reflecting global caution ahead of the policy release.

After the cash open, major U.S. indexes traded mixed and near flat. The Nasdaq Composite was roughly 0.2% lower, while the Dow rose about 100 points amid sector rotations and muted breadth. U.S. equities remained near record highs, with gold-related stocks among the relative outperformers.

Market technicians described the pre-decision setup as a routine Fed-day pattern consistent with previous FOMC meetings. Commodities showed more activity than equities, with silver gaining strength while soybeans declined.

Powell Guidance and Dot Plot Focus

The FOMC scheduled its policy statement and the Summary of Economic Projections (SEP) for 2:00 p.m. ET [source:Federal Reserve]. The SEP will include updated forecasts for growth, unemployment, and inflation. The “dot plot” will reveal policymakers’ expectations for the federal funds rate in 2026 and beyond.

Investors widely expected the committee to keep the policy rate unchanged, focusing instead on Powell’s press conference remarks about inflation progress, labor-market conditions, and the timing and pace of any future rate cuts. Because many traders were conservatively positioned, more decisive moves may follow the statement and Powell’s Q&A as market participants reassess the updated projections and the policy path signaled by the committee.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Chewy Q3 2025 Earnings Beat, Shares Reverse

Chewy Q3 2025 Earnings Beat, Shares Reverse

Chewy Q3 2025 earnings showed an EPS beat and margin gains, but shares reversed after an initial uptick, creating near-term trading caution.

GE Vernova Stock Climbs After Guidance Upgrade

GE Vernova Stock Climbs After Guidance Upgrade

GE Vernova stock rose after the company raised multi-year targets and boosted dividends and buybacks, pushing traders to price stronger cash-flow outlook.

Designer Brands Earnings Beat Fuels Profit Guidance

Designer Brands Earnings Beat Fuels Profit Guidance

Designer Brands earnings beat and management raised fiscal 2025 adjusted operating income guidance to $50.0-$55.0 million, prompting near-term re-rating.

Cracker Barrel Q1 Results Show Loss and Guidance Cut

Cracker Barrel Q1 Results Show Loss and Guidance Cut

Cracker Barrel Q1 results show a quarterly loss and lower fiscal-2026 targets, a setback that could pressure investor sentiment and share trading.

GameStop Q3 Earnings Miss, Collectibles Surge

GameStop Q3 Earnings Miss, Collectibles Surge

GameStop Q3 earnings showed a revenue miss on Dec. 9, 2025 as collectibles and SG&A cuts delivered EPS, likely prompting share volatility and rebalancing.

Pfizer YaoPharma Deal Brings YP05002 In-House

Pfizer YaoPharma Deal Brings YP05002 In-House

Pfizer YaoPharma deal gives Pfizer exclusive rights to oral GLP-1 candidate, expanding its obesity pipeline and putting traders on clinical milestones.